- Ivabradin ovlivňuje příznivě prognózu nemocných se stabilní anginou pectoris - podskupinová analýza ze studie BEAUTIFUL2009 | 1. lékařská fakulta
- Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: subgroup analysis of CASTOR based on cytogenetic risk2020 | 1. lékařská fakulta
- Isatuximab plus carfilzomib and dexamethasone in relapsed multiple myeloma patients with high-risk cytogenetics: IKEMA subgroup analysis2022 | 1. lékařská fakulta
- Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone in elderly patients with relapsed multiple myeloma: IKEMA subgroup analysis2022 | 1. lékařská fakulta
- 1-Year outcomes with COMBO stents in small vessel coronary disease: Subgroup analysis from the COMBO collaboration2020 | Publikace bez příslušnosti k fakultě
- Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis : A Subgroup Analysis From Three International Cohorts2021 | 1. lékařská fakulta
- Isatuximab plus pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma according to prior lines of treatment and refractory status: ICARIA-MM subgroup analysis2021 | Lékařská fakulta v Hradci Králové
- Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL-8a mabtenance trial2019 | 1. lékařská fakulta, Ústřední knihovna, Lékařská fakulta v Hradci Králové
- Effects of Teriparatide Compared with Risedronate on the Risk of Fractures in Subgroups of Postmenopausal Women with Severe Osteoporosis: The VERO Trial2018 | 1. lékařská fakulta
- Adjuvant trastuzumab emtansine (T-DM1) vs trastuzumab (H) in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: KATHERINE subgroup analysisPublikace bez příslušnosti k fakultě
- Stratification of lymph node metastases as macrometastases, micrometastases, or isolated tumor cells has no clinical implication in patients with cervical cancer: Subgroup analysis of the SCCAN project2023 | 1. lékařská fakulta, Lékařská fakulta v Plzni
- Serum 25-hydroxy-vitamin D and the risk of fractures in the teriparatide versus risedronate VERO clinical trial2019 | 1. lékařská fakulta
- Inosine pranobex is safe and effective for the treatment of subjects with confirmed acute respiratory viral infections: analysis and subgroup analysis from a Phase 4, randomised, placebo-controlled, double-blind study2016 | 2. lékařská fakulta
- Calcipotriene and Betamethasone Dipropionate PAD-Cream Demonstrates Greater Treatment Efficacy in Patients with Moderate-to-Severe Psoriasis Compared to Topical Suspension/Gel: A Subgroup Analysis of Two Phase 3 Studies2023 | 3. lékařská fakulta
- Srdeční frekvence jako prognostický rizikový faktor u nemocných s ischemickou chorobou srdeční a systolickou dysfunkcí levé komory (BEAUTIFUL): podskupinová analýza randomizované kontrolované studie2008 | 1. lékařská fakulta
- Initiation of sacubitril/valsartan shortly after hospitalisation for acutely decompensated heart failure in patients with newly diagnosed (de novo) heart failure: a subgroup analysis of the TRANSITION study2020 | 1. lékařská fakulta
- Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced-stage, classical Hodgkin lymphoma: A prespecified subgroup analysis of high-risk patients from the ECHELON-1 study2021 | 1. lékařská fakulta, Lékařská fakulta v Hradci Králové
- First-cycle rash and survival in patients with advanced non-small-cell lung cancer receiving cetuximab in combination with first-line chemotherapy: A subgroup analysis of data from the FLEX phase 3 study2011 | 3. lékařská fakulta
- Decitabine improves response rate and prolongs progression-free survival in older patients with newly diagnosed acute myeloid leukemia and with monosomal karyotype: A subgroup analysis of the DACO-016 trial2018 | Ústřední knihovna, Lékařská fakulta v Plzni
- Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: Prespecified subgroup analyses from the VELOUR trial2014 | 2. lékařská fakulta
- Subgroup analysis in RAISE: a randomized, double-blind phase III study of irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) plus ramucirumab or placebo in patients with metastatic colorectal carcinoma progression(aEuro)2016 | Publikace bez příslušnosti k fakultě
- Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the CONFIRM study2013 | 1. lékařská fakulta
- The efficacy and safety of valsartan and a combination of valsartan and hydrochlorothiazide in the treatment of patients with mild to moderate arterial hypertension: a subgroup analysis of the effect of valsartan and its combination with hydrochlorothiazide on pulse wave velocity and central blood pressure2018 | 1. lékařská fakulta
- Consistent efficacy of daclizumab beta across patient demographic and disease activity subgroups in patients with relapsing-remitting multiple sclerosis2017 | 1. lékařská fakulta
- Efficacy of daclizumab beta versus intramuscular interferon beta-1a on disability progression across patient demographic and disease activity subgroups in DECIDE2018 | 1. lékařská fakulta
- An Adsorptive and Antioxidant Vaginal Gel Clears High-Risk HPV- and p16/Ki-67-Associated Abnormal Cytological Cervical Findings: A post-hoc Subgroup Analysis of a Prospective Randomized Controlled Trial on CIN2 and p16 Positive CIN12021 | Publikace bez příslušnosti k fakultě
- Účinnost natalizumabu u pacientů s relabující roztroušenou sklerózou : analýzy podskupin AFFIRM a SENTINEL2009 | 1. lékařská fakulta
- Úloha srdeční frekvence u pacientů s ischemickou chorobou srdeční2009 | 1. lékařská fakulta
- Bezpečnost a účinnost intreavenózního valproátu v léčbě akutní migrény.2007 | 1. lékařská fakulta
- Real-world effectiveness and safety of omalizumab in patients with uncontrolled severe allergic asthma from the Czech Republic2019 | 2. lékařská fakulta, Lékařská fakulta v Plzni, Lékařská fakulta v Hradci Králové